4.6 Article

Diversity of Antiviral IgG Effector Activities Observed in HIV-Infected and Vaccinated Subjects

Related references

Note: Only part of the references are listed.
Review Immunology

Prospects for engineering HIV-specific antibodies for enhanced effector function and half-life

Austin W. Boesch et al.

CURRENT OPINION IN HIV AND AIDS (2015)

Article Biochemistry & Molecular Biology

Broadly Neutralizing Anti-HIV-1 Antibodies Require Fc Effector Functions for In Vivo Activity

Stylianos Bournazos et al.

Article Medicine, Research & Experimental

FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial

Shuying S. Li et al.

JOURNAL OF CLINICAL INVESTIGATION (2014)

Review Biochemical Research Methods

Establishment and maintenance of a PBMC repository for functional cellular studies in support of clinical vaccine trials

Anna Sambor et al.

JOURNAL OF IMMUNOLOGICAL METHODS (2014)

Article Immunology

Epitope target structures of Fc-mediated effector function during HIV-1 acquisition

George K. Lewis et al.

CURRENT OPINION IN HIV AND AIDS (2014)

Article Immunology

Opportunities to Exploit Non-Neutralizing HIV-Specific Antibody Activity

Margaret E. Ackerman et al.

CURRENT HIV RESEARCH (2013)

Article Medicine, Research & Experimental

Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity

Margaret E. Ackerman et al.

JOURNAL OF CLINICAL INVESTIGATION (2013)

Article Multidisciplinary Sciences

Diverse specificity and effector function among human antibodies to HIV-1 envelope glycoprotein epitopes exposed by CD4 binding

Yongjun Guan et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Article Multidisciplinary Sciences

Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG

Georgia D. Tomaras et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Article Medicine, General & Internal

Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial

Barton F. Haynes et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Biochemical Research Methods

High-Throughput Quantitative Analysis of HIV-1 and SIV-Specific ADCC-Mediating Antibody Responses

Justin Pollara et al.

CYTOMETRY PART A (2011)

Article Immunology

Activation of NK Cells by ADCC Antibodies and HIV Disease Progression

Amy W. Chung et al.

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2011)

Article Biochemical Research Methods

A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples

Margaret E. Ackerman et al.

JOURNAL OF IMMUNOLOGICAL METHODS (2011)

Article Immunology

Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy

Florencia Pereyra et al.

JOURNAL OF INFECTIOUS DISEASES (2008)

Article Chemistry, Multidisciplinary

Role of particle size in phagocytosis of polymeric microspheres

Julie A. Champion et al.

PHARMACEUTICAL RESEARCH (2008)

Article Multidisciplinary Sciences

Fc receptor but not complement binding is important in antibody protection against HIV

Ann J. Hessell et al.

NATURE (2007)

Article Biochemical Research Methods

A simplified method for the rapid fluorometric assessment of antibody-dependent cell-mediated cytotoxicity

VR Gómez-Román et al.

JOURNAL OF IMMUNOLOGICAL METHODS (2006)

Article Multidisciplinary Sciences

Divergent immunoglobulin G subclass activity through selective Fc receptor binding

F Nimmerjahn et al.

SCIENCE (2005)